Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 15, 2020
Reporting Period: Event reported on December 14, 2020.
Business Overview: The registrant is an emerging growth company incorporated in North Carolina, with principal executive offices in Charlotte, NC. Securities registered include Common Stock (YCBD) and 8.0% Series A Cumulative Convertible Preferred Stock (YCBDpA) on the NYSE American.
Key Financial Metrics
This filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on a specific corporate action regarding preferred stock dividends.
Material Changes
Dividend Declaration: On December 14, 2020, the company declared a monthly cash dividend for holders of its 8.0% Series A Cumulative Convertible Preferred Stock.
- Dividend Amount: $0.0667 per share.
- Record Date: January 1, 2021.
- Payment Date: January 15, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies beyond the specific dividend event. No unusual items were disclosed in this report.
Investor Verification Checklist
- Verify the record date (January 1, 2021) to confirm eligibility for the $0.0667 per share dividend.
- Confirm the payment date of January 15, 2021, for cash flow planning.
- Review the terms of the 8.0% Series A Cumulative Convertible Preferred Stock to understand conversion rights and cumulative dividend obligations.
- Note that this filing does not contain updated operational or financial performance data for the period.